Roche to Invest Over $700 Million in New North Carolina Facility to Support Next-Gen Obesity Therapeutics

Gelonghui May 12 | Roche Group (Roche) announced on Monday that it plans to invest over $700 million in a new pharmaceutical production plant in North Carolina, USA. The company stated that the new plant will eventually support Roche and its subsidiary Genentech's future next-generation obesity drug portfolio, and the initial investment may expand in the future based on business needs and the U.S. policy environment.